SCOPUS 정보 검색 플랫폼

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 4, 2000, Pages 319-326

Antibody therapy of acute myelogenous leukemia

(1) Jurcic, J G a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMTUZUMAB OZOGAMICIN; HUM 195; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALPHA RADIATION; ANTINEOPLASTIC ACTIVITY; CANCER REGRESSION; ELECTRON; HUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOIMMUNOTHERAPY; REVIEW;

EID: 0033779688 PISSN: 10849785 EISSN: None Source Type: Journal
DOI: 10.1089/cbr.2000.15.319 Document Type: Review

Times cited : (20)

References (33)

1
- 0021999511
- Heterogeneity of clonogenic cells in acute myeloblastic leukemia
- (1985) J Clin Invest , vol.75 , pp. 746
- Sabbath, K.D.¹ Ball, E.D.² Larcom, P.³ Davis, R.B.⁴ Griffin, J.D.⁵

2
- 0022806814
- The L4F3 antigen is expressed by unipotent colony-forming cells but not by their precursors
- (1986) Blood , vol.68 , pp. 1030
- Andrews, R.G.¹ Takahashi, M.² Segal, G.M.³

3
- 0027941369
- Intensive postremission chemotherapy in adults with acute myeloid leukemia
- (1994) New Engl J Med , vol.331 , pp. 896
- Mayer, R.J.¹ Davis, R.B.² Schiffer, C.A.³

4
- 0032480930
- Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
- (1998) New Engl J Med , vol.339 , pp. 1649
- Cassileth, P.A.¹ Harrington, D.P.² Appelbaum, F.R.³

5
- 0033574433
- Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells
- (1999) J Biol Chem , vol.274 , pp. 10877
- Weisburg, J.H.¹ Roepe, P.D.² Dzekunov, S.³ Scheinberg, D.A.⁴

6
- 0026020135
- A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: Specific bone marrow targeting and internalization of radionuclide
- (1991) J Clin Oncol , vol.9 , pp. 478
- Scheinberg, D.A.¹ Lovett, D.² Divgi, D.R.³

7
- 0027092901
- Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies
- (1992) Cancer Res , vol.148 , pp. 6761
- Caron, P.C.¹ Co, M.S.² Bull, M.K.³

8
- 0028231359
- A phase IB trial of humanized antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity
- (1994) Blood , vol.83 , pp. 1760
- Caron, P.C.¹ Jurcic, J.G.² Scott, A.M.³

9
- 0028825883
- Elimination of human leukemia by monoclonal antibodies in an athymic nude mouse model
- (1995) Clin Cancer Res , vol.1 , pp. 1179
- Xu, Y.¹ Scheinberg, D.A.²

10
- 0031749971
- Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia
- (1998) Clin Cancer Res , vol.4 , pp. 1421
- Caron, P.C.¹ Dumont, L.² Scheinberg, D.A.³

11
- 0001847295
- Humanized monoclonal anti-CD33 antibody HuM195 in the treatment of relapsed/refractory acute myelogenous leukemia: Preliminary report of a phase II study
- (1999) Proc Am Soc Clin Oncol , vol.18
- Feldman, E.¹ Kalaycio, M.² Schulman, P.³

12
- 0023752982
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
- (1988) Blood , vol.72 , pp. 567
- Huang, M.E.¹ Ye, Y.C.² Chen, S.R.³

13
- 0025201879
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical result
- (1990) Blood , vol.76 , pp. 1704
- Castaigne, S.¹ Chomienne, C.² Daniel, M.T.³ Berger, R.⁴ Fenaux, P.⁵ Degos, L.⁶

14
- 0025882306
- Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
- (1991) N Engl J Med , vol.324 , pp. 1385
- Warrell R.P., Jr.¹ Frankel, S.R.² Miller W.H., Jr.³

15
- 0033982749
- Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia
- (2000) Clin Cancer Res , vol.6 , pp. 372
- Jurcic, J.G.¹ DeBlasio, A.² Dumont, L.³

16
- 0028904693
- Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (HuM195) (anti-CD33) in myelogenous leukemia
- (1995) Clin Cancer Res , vol.1 , pp. 63
- Caron, P.C.¹ Lai, L.² Scheinberg, D.A.³

17
- 0032724046
- A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low dose interleukin-2 (IL-2) in acute myelogenous leukemia
- (1999) Clin Cancer Res , vol.5 , pp. 2748
- Kossman, S.E.¹ Scheinberg, D.A.² Jurcic, J.G.³

18
- 0029146320
- Impact of the high tyrosine fraction in complementarity determining regions: Measured and predicted effects of radioiodination of IgG immunoreactivity
- (1995) Mol Immunol , vol.32 , pp. 865
- Nikula, T.¹ Bocchia, M.² Curcio, M.J.³

19
- 0020694773
- Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice
- (1983) Cancer Res , vol.43 , pp. 265
- Scheinberg, D.A.¹ Strand, M.²

20
- 0031715792
- Radioimmunotherapy with alpha-emitting nuclides
- (1998) Eur J Nucl Med , vol.25 , pp. 1341
- McDevitt, M.R.¹ Sgouros, G.² Finn, R.D.³

21
- 0026592099
- The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia
- (1992) Transplantation , vol.54 , pp. 829
- Appelbaum, F.R.¹ Matthews, D.C.² Eary, J.F.³

22
- 0028936249
- 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation
- (1995) Blood , vol.85 , pp. 1122
- Matthews, D.C.¹ Appelbaum, F.R.² Eary, J.F.³

23
- 0033566795
- 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
- (1999) Blood , vol.94 , pp. 1237
- Matthews, D.C.¹ Appelbaum, F.R.² Eary, J.F.³

24
- 0000602090
- 131I-anti-CD45 antibody plus busulfan/cyclophosphamide in matched related transplants for AML in first remission
- (1996) Blood , vol.88
- Matthews, D.C.¹ Appelbaum, F.R.² Eary, J.F.³

25
- 0027499283
- Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias
- (1993) J Clin Oncol , vol.11 , pp. 294
- Schwartz, M.A.¹ Lovett, D.R.² Redner, A.³

26
- 12344290647
- Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias
- (1995) Cancer Res , vol.55
- Jurcic, J.G.¹ Caron, P.C.² Nikula, T.K.³

27
- 0003341452
- Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33) in myeloid leukemia
- in press
- (2000) Proc Am Soc Clin Oncol
- Jurcic, J.G.¹ Divgi, C.R.² McDevitt, M.R.³

28
- 0032888303
- 213Bi-labeled antibody constructs for clinical use
- (1999) J Nucl Med , vol.40 , pp. 1722
- McDevitt, M.R.¹ Finn, R.D.² Ma, D.³

29
- 0032898445
- Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: Pharmacokinetics, bioactivity, toxicity, and chemistry
- (1999) J Nucl Med , vol.40 , pp. 166
- Nikula, T.K.¹ McDevitt, M.R.² Finn, R.D.³

30
- 0002769232
- Phase I trial of targeted alpha-particle therapy for myeloid leukemia with bismuth-213-HuM195 (anti-CD33)
- (1999) Proc Am Soc Clin Oncol , vol.18
- Jurcic, J.G.¹ McDevitt, M.R.² Sgouros³

31
- 0032694040
- 213Bi-HuM195 (anti-CD33) in patients with leukemia
- (1999) J Nucl Med , vol.40 , pp. 1935
- Sgouros, G.¹ Ballangrud, A.M.² Jurcic, J.G.³

32
- 0033151526
- Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of anti-CD33 calicheamicin immunoconjugate
- (1999) Blood , vol.93 , pp. 3678
- Sievers, E.L.¹ Appelbaum, F.R.² Speilberger, R.T.³

33
- 0001290358
- Efficacy and safety of CMA-676 in patients with AML in first relapse
- (1999) Blood , vol.94
- Sievers, E.L.¹ Larson, R.A.² Estey, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.